Protalix BioTherapeutics (NYSEMKT:PLX) says the Brazilian Ministry of Health commits to purchase ~$40M worth of the Gaucher disease treatment alfataliglicerase per year for two years and at least that much there after as part of a "technology transfer" agreement. PLX +8.3% premarket. (PR)
Protalix BioTherapeutics (NYSEMKT:PLX) says the Brazilian Ministry of Health commits to purchase...
Recommended For You
More Trending News
About PLX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PLX | - | - |
| Protalix BioTherapeutics, Inc. | ||